Renin inhibitors
William J. Greenlee · Medicinal Research Reviews · 1990
Since the early 1980s, an intensive effort has been focused on the development of orally effective and long-acting inhibitors of renin. During this time, in vitro potency has increased greatly, with several transition-state inhibitor designs yielding inhibitors with subnanomolar IC50 values. In the meantime, both the molecular weight and peptide character of the inhibitors has decreased as important binding elements have been focused into smaller and more stable structures. The resulting inhibitors have shown promising activities in several in vivo models and (in two cases) in man. Nevertheless, renin inhibitors reported to date have limited oral bioavailability and short duration of action, and improvements in both will be necessary for them to compete effectively with ACE inhibitors. Renin inhibitors which have entered clinical studies have at least one naturally occurring amino acid and three or more amide bonds. It is reasonable to expect that continued development will produce wholly nonpeptide inhibitors with still lower MW, and it may be these "second-generation" inhibitors which will succeed as therapeutic agents. Development of orally effective and long-acting inhibitors of renin will enable their long-term antihypertensive efficacy and possible advantages over ACE inhibitor to be investigated.
Cited by 248 works. doi:10.1002/med.2610100203
Authors
References
- On the size of the active site in proteases. I. Papain
- Chemistry and Biology of Peptides
- PEPSTATIN, A NEW PEPSIN INHIBITOR PRODUCED BY AGTINOMYGETES
- Renin-angiotensin system: biochemistry and mechanisms of action.
- Angiotensinogen Is Related to the Antitrypsin-Antithrombin-Ovalbumin Family
- Analog approaches to the structure of the transition state in enzyme reactions
- Three-dimensional structure, specificity and catalytic mechanism of renin
- Proteinase Inhibitors
- HTLV-III gag Protein Is Processed in Yeast Cells by the Virus pol -Protease
- Molecular biology of tumor viruses. RNA tumor viruses.